Cinchocaine


Concise Prescribing Info
Indications/Uses
Listed in Dosage.
Dosage/Direction for Use
Adult : Topical Surface anesth As 1% cream/oint: Apply as directed. Haemorrhoids As 0.05% oint: Apply twice daily and after each bowel movement. Per supp contains cinchocaine 5 mg: Insert 1 supp twice daily and after each bowel movement.
Dosage Details
Topical/Cutaneous
Surface anaesthesia
Adult: Up to 1% in cream and ointment.

Topical/Cutaneous
Haemorrhoids
Adult: As 0.05% w/w ointment (in combination with hydrocortisone): Apply onto the affected area in the morning and evening and after each stool. As suppository containing 5 mg/unit (in combination with hydrocortisone): Insert 1 suppository in the morning and evening and after each stool.
Contraindications
Complete heart block; pyogenic infection at or near the skin. Application to inflamed or infected tissues or to damaged skin mucosa; instillation into the middle ear.
Special Precautions
Elderly; debilitated patients; child; epilepsy; impaired cardiac conduction or respiratory function; shock; hepatic impairment; myasthenia gravis. Do not to rub or touch the eye while anaesthesia persists. Avoid application for prolonged periods and to extensive areas. Pregnancy, lactation.
Adverse Reactions
Restlessness; excitement; nervousness; paraesthesias; dizziness; tinnitus; blurred vision; nausea; vomiting; muscle twitching; tremors; convulsions; hypotension; bradycardia; arrhythmias; cardiac arrest.
Action
Description: Cinchocaine prevents or diminishes nerve impulse conduction near to the site of admin. It also has membrane-stabilising effect owing to decrease of permeability of the nerve cell to sodium ions.
Onset: Up to 15 minutes.
Duration: 2-4 hr.
Storage
Store below 25°C.
Disclaimer: This information is independently developed by MIMS based on Cinchocaine from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to MIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, MIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2020 MIMS. All rights reserved. Powered by MIMS.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in